A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma

Clinical trial NCT02343536 · COMPLETED

Trial details

NCT number: NCT02343536
Sponsor: Celgene
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoma, Large B-Cell, Diffuse Lymphoma, Follicular

Start date: 2015-04-29
Primary completion: 2020-01-29
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.